IP Landscape – mRNA Characterization

A leading global biopharma company sought a comprehensive IP landscape review to identify market gaps and enhance its competitive edge. Stellarix’s consulting insights helped the client expand into new markets and strategically position their IP portfolio by highlighting high-value technologies and untapped areas for patent filing.

Client Background:

A global biopharma leader focused on immune system research and AI-driven innovation, specializing in vaccines, rare disease therapies, immunology, oncology, and neurology.

Engagement Objective:

To conduct a comprehensive Landscape search focusing on the characterization of mRNA constructs used in vaccine manufacturing, specifically aiming to identify the methods, assays, processes, and key players involved in mRNA characterization.

• A detailed overview of intellectual property (IP) trends, patents, and proprietary methods associated with the characterization of mRNA constructs used in vaccine development.
• Identify and evaluate the various methods, assays, and processes utilized for the characterization of mRNA constructs, including their role in assessing stability, translation efficiency, and interaction with proteins.
• Profile and map the leading companies, startups, academic institutions, key opinion leaders (KOLs), and research organizations that develop and use assays for mRNA characterization.

Methodology:

• Conducted a detailed review of patents and scientific publications to track innovations and key trends in mRNA characterization techniques and assays used for vaccine development.
• Identified and did profiling of key companies, startups, and research institutions, assessing their technologies, market positioning, and contributions to mRNA characterization for vaccine development.
• Engaged with industry experts and key opinion leaders to gather insights into emerging technologies, best practices, and collaborative efforts in the field of mRNA characterization.
• Evaluated and compared existing mRNA characterization methods, assays, and processes to identify the most efficient techniques being utilized in vaccine development and production.

Client Impact:

• The insights enabled the client to refine its focus on developing more effective mRNA vaccine candidates by understanding key characterization methods, optimizing assay processes, and identifying market gaps.
• By profiling top assignees, identifying high-value technologies, and analyzing innovation filing trends, the clients strategically positioned their IP portfolio, uncovering new areas for patent filing and market expansion.